oncology

You have access
[¹⁸F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk and Hee-Don Chae

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1869-1875; DOI: https://doi.org/10.2967/jnumed.124.268253
Open Access
Precision Oncology in Melanoma: Changing Practices
Sean C. Dougherty, William L. Flowers and Elizabeth M. Gaughan

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1838-1845; DOI: https://doi.org/10.2967/jnumed.124.267781
You have access
Clinical Factors That Influence Repeat ⁶⁸Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative ⁶⁸Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study
Pan Thin, Masatoshi Hotta, Andrei Gafita, Tristan Grogan, Johannes Czernin, Jeremie Calais and Ida Sonni

Journal of Nuclear Medicine October 1, 2024, 65 (10) 1571-1576; DOI: https://doi.org/10.2967/jnumed.124.267591
$Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up$

Open Access
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up
Stefano Severi, Ilaria Grassi, Alberto Bongiovanni, Silvia Nicolini, Irene Marini, Donatella Arpa, Nicoletta Ranallo, Irene Azzali, Valentina Di Iorio, Anna Sarnelli, Monti Manuela, Elena Amadori, Lucia Fabbri, Daniela Bartolini, Luigino Tosatto, Francesco Di Meco, Lorena Gurrieri, Nada Riva, Luana Calabro, Federica Matteucci, Giovanni Paganelli and Maddalena Sansovini

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1409-1415; DOI: https://doi.org/10.2967/jnumed.123.266956
Open Access
Interreader and Intrareader Reproducibility of ¹⁸F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies
Phillip H. Kuo, Giuseppe Esposito, Gary A. Ulaner, Don Yoo, Katherine Zukotynski, Gregory C. Ravizzini, Ross Penny, Matthew P. Miller, Albert Chau, Phillip Davis, Brian F. Chapin, David M. Schuster and on behalf of the SPOTLIGHT and LIGHTHOUSE study groups

Journal of Nuclear Medicine August 1, 2024, 65 (8) 1239-1243; DOI: https://doi.org/10.2967/jnumed.123.267306
You have access
Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center
Wanqi Chen, Yinghe Li, Zhijian Li, Yongluo Jiang, Yingpu Cui, Jiling Zeng, Yiwen Mo, Si Tang, Shatong Li, Lei Liu, Yumo Zhao, Yingying Hu and Wei Fan

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 54S-63S; DOI: https://doi.org/10.2967/jnumed.123.266948
You have access
Real-World Experience with ¹⁷⁷Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval
Abuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, Sarasa T. Kim, Rachelle K. Saelee, Amanda Morley, Roxanna Juarez, Courtney Lawhn-Heath, Yingbing Wang, Ivan de Kouchkovsky and Thomas A. Hope

Journal of Nuclear Medicine May 1, 2024, 65 (5) 735-739; DOI: https://doi.org/10.2967/jnumed.123.266842
Open Access
Promising Candidate Prognostic Biomarkers in [¹⁸F]FDG PET Images: Evaluation in Independent Cohorts of Non–Small Cell Lung Cancer Patients
Narinée Hovhannisyan-Baghdasarian, Marie Luporsi, Nicolas Captier, Christophe Nioche, Vesna Cuplov, Erwin Woff, Nadia Hegarat, Alain Livartowski, Nicolas Girard, Irène Buvat and Fanny Orlhac

Journal of Nuclear Medicine April 1, 2024, 65 (4) 635-642; DOI: https://doi.org/10.2967/jnumed.123.266331
You have access
Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Helena Lanzafame, Stefan Kasper, Michael Nader, Claudia Kesch, Bastian von Tresckow, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler

Journal of Nuclear Medicine March 1, 2024, 65 (3) 372-378; DOI: https://doi.org/10.2967/jnumed.123.266652
You have access
Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors
Sarah E. Poplawski, Robin M. Hallett, Mark H. Dornan, Kyle E. Novakowski, Shuang Pan, Anthony P. Belanger, Quang-De Nguyen, Wengen Wu, Albert E. Felten, Yuxin Liu, Shin Hye Ahn, Valerie S. Hergott, Barry Jones, Jack H. Lai, Joe A.B. McCann and William W. Bachovchin

Journal of Nuclear Medicine January 1, 2024, 65 (1) 100-108; DOI: https://doi.org/10.2967/jnumed.123.266345

Main menu

User menu

Search

oncology

Pages